New Delhi: There is news of great relief for diabetes patients. Danish pharmaceutical company Novo Nordisk has launched the world’s first once-a-week basal insulin ‘Awiqli’ in India. This new insulin is for adult patients suffering from type-1 and type-2 diabetes. Its biggest feature is that now instead of taking daily injections, patients will have to inject insulin only 52 times in a year.
Relief will be provided by daily injections
Till now, most diabetes patients had to take insulin daily, which required about 365 injections in a year. The new weekly insulin can reduce this problem to a great extent. Doctors believe that this will make treatment easier for patients and they will not stop taking insulin regularly.
How much is the price?
The company has fixed the price of a pack of 700 units at Rs 2,611. That means the per unit cost is around Rs 3.73. The company claims that it is 30 to 40 percent cheaper than many existing daily basal insulins. If a patient needs 10 units of insulin daily, he will need about 70 units of insulin a week.
Why is this needed in India?
India is among those countries in the world where the number of diabetes patients is highest. Crores of people in the country are suffering from diabetes, while a large number of people are in pre-diabetes condition. Experts say that many patients do not start insulin on time due to fear or inconvenience of daily injections. In such a situation, taking insulin only once a week can solve this problem to a great extent.
treatment will be easy
The new insulin will be given through FlexTouch pen device, which will make it easier to use. Clinical studies have also shown that this insulin has proven to be as effective as or better than daily basal insulin in controlling blood sugar. Besides, its security has also been found satisfactory.
It is believed that this new technology can change the way diabetes is treated in India. If more patients start insulin therapy on time and continue treatment regularly, it may also help reduce complications associated with diabetes.
-
Startup Ecosystem Mourns The Passing Of Accel's Akhilesh Agarwal
-
Azizi Developments seeks 4,000 subcontractors for UAE construction pipeline
-
J&K Monsoon Mayhem: Landslide Hits Vaishno Devi Track After Heavy Rains, Battery Car Service Suspended Temporarily
-
5 High-Protein Paneer Recipes That Are Healthy, Delicious, and Easy to Make
-
FADA Backs Delhi's EV Push, Says Transition Will Be Challenging but Essential for the Future
